BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2858990)

  • 1. Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline.
    Miraglia CC; Greenberg CS
    Anal Biochem; 1985 Jan; 144(1):165-71. PubMed ID: 2858990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
    Greenberg CS; Miraglia CC
    Blood; 1985 Aug; 66(2):466-9. PubMed ID: 2861869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets.
    Greenberg CS; Shuman MA
    J Biol Chem; 1984 Dec; 259(23):14721-7. PubMed ID: 6150044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII.
    Greenberg CS; Achyuthan KE; Fenton JW
    Blood; 1987 Mar; 69(3):867-71. PubMed ID: 2880615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.
    Laudano AP; Doolittle RF
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3085-9. PubMed ID: 277910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of factor XIIIa (active fibrin-stabilizing factor) in normal plasma.
    Nelson JC; Lerner RG
    Blood; 1978 Sep; 52(3):581-91. PubMed ID: 678674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of plasma factor XIII binding to fibrin in vitro.
    Greenberg CS; Dobson JV; Miraglia CC
    Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin is a substrate for blood coagulation factor XIIIa.
    Bale MD; Mosher DF
    Biochemistry; 1986 Sep; 25(19):5667-73. PubMed ID: 2877688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue.
    Coyne CP; Smith JE; DeBowes RM
    Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin binding to fibrin is necessary for fibrin polymers to enhance factor XIIIa formation.
    Greenberg CS; Achyuthan KE; Miraglia CC
    Semin Thromb Hemost; 1986 Jul; 12(3):226-7. PubMed ID: 2877494
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of factor XIII with fibrin as substrate and cofactor.
    Hornyak TJ; Shafer JA
    Biochemistry; 1992 Jan; 31(2):423-9. PubMed ID: 1731900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.
    Plow EF; Marguerie G
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3711-5. PubMed ID: 6954514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoke contains anticoagulants against fibrin aggregation and factor XIIIa in plasma.
    Galanakis DK; Laurent P; Janoff A
    Science; 1982 Aug; 217(4560):642-5. PubMed ID: 6124042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets.
    Kreager JA; Devine DV; Greenberg CS
    Thromb Haemost; 1988 Aug; 60(1):88-93. PubMed ID: 2903577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.